Triple
T22452859
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Regulation (EU) 2019/5 |
E555035
|
entity |
| Predicate | relatedTo |
P37
|
FINISHED |
| Object | EU medicines regulatory network |
—
|
NE NERFINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: EU medicines regulatory network | Statement: [Regulation (EU) 2019/5, relatedTo, EU medicines regulatory network]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: EU medicines regulatory network Context triple: [Regulation (EU) 2019/5, relatedTo, EU medicines regulatory network]
-
A.
European medicines regulatory authorities
chosen
European medicines regulatory authorities are national and regional agencies in Europe responsible for evaluating, authorizing, and monitoring the safety, quality, and efficacy of medicinal products.
-
B.
European Union Drugs Agency
The European Union Drugs Agency is the EU’s central body responsible for providing scientific analysis, monitoring, and policy support on drugs and drug addiction across member states.
-
C.
European Medicines Agency
The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
-
D.
European Directorate for the Quality of Medicines & HealthCare
The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
-
E.
Committee for Medicinal Products for Human Use
The Committee for Medicinal Products for Human Use is the European Medicines Agency’s expert body responsible for evaluating and providing scientific opinions on the safety, quality, and efficacy of medicines for human use in the European Union.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e11e5113208190ab58c6b595f9d1d0 |
completed | April 16, 2026, 5:37 p.m. |
| NER | Named-entity recognition | batch_69f15b4d6368819082cafbbd83339fbf |
completed | April 29, 2026, 1:13 a.m. |
Created at: April 16, 2026, 8:48 p.m.